Evofem Bio has launched its Phase 2b/3 clinical trial Amprevence and is accepting enrollees to see how its non-hormonal, on-demand and surfactant-free drug Amphora helps in the prevention of female gonorrhea and urogenital chlamydia.
New research has found that exposing chlamydia to the gut could protect against a possible infection in the genital tract. Chlamydia is one of the most common sexually transmitted diseases that can cause pelvic inflammatory disease, ectopic pregnancy and infertility.
Help stop the spread of STDs by knowing your status. Get tested today!